REGENXBIO Aktie
6,70
EUR
-0,17
EUR
-2,48
%
7,79
USD
-0,10
USD
-1,27
%
REGENXBIO jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
REGENXBIO Aktie Analyse
| 18.06.19 | REGENXBIO Buy | Chardan Capital Markets | |
| 05.06.19 | REGENXBIO Buy | Chardan Capital Markets | |
| 17.12.18 | REGENXBIO Buy | Chardan Capital Markets | |
| 08.08.18 | REGENXBIO Buy | Chardan Capital Markets | |
| 10.07.18 | REGENXBIO Buy | Chardan Capital Markets | |
| 09.05.18 | REGENXBIO overweight | Barclays Capital | |
| 09.04.18 | REGENXBIO Buy | Chardan Capital Markets | |
| 13.02.18 | REGENXBIO Neutral | Mizuho | |
|
Werbung
|
|||
| 09.11.17 | REGENXBIO Buy | Chardan Capital Markets | |
| 09.08.17 | REGENXBIO Buy | Chardan Capital Markets | |
| 11.04.17 | REGENXBIO Buy | Chardan Capital Markets | |
| 20.10.15 | REGENXBIO Buy | Chardan Capital Markets | |
Werbung
Werbung